FDA Suspends Use of Glaxo Antibody Drug in USA
Federal regulators said they are suspending the use of a monoclonal antibody drug known as sotrovimab to treat high-risk Covid-19 patients in the United States. unlikely to be effective Against the Omicron sub-variant known as BA.2. BA.2 is highly contagious and now raid in the United States, four months later first detection in the country. …
Continue reading “FDA Suspends Use of Glaxo Antibody Drug in USA”